These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The vaccine is dead--long live the vaccine. Snounou G, Rénia L. Trends Parasitol; 2007 Apr 10; 23(4):129-32. PubMed ID: 17300988 [Abstract] [Full Text] [Related]
10. [Vaccination against malaria. Disappointments and hopes]. Ambroise-Thomas P. Bull Acad Natl Med; 1997 Nov 10; 181(8):1637-48; discussion 1648-50. PubMed ID: 9554123 [Abstract] [Full Text] [Related]
11. Towards a vaccine against malaria. McGregor IA. Br J Biomed Sci; 1993 Mar 10; 50(1):35-42. PubMed ID: 8032294 [Abstract] [Full Text] [Related]
12. Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials. Nardin E, Zavala F, Nussenzweig V, Nussenzweig RS. Parassitologia; 1999 Sep 10; 41(1-3):397-402. PubMed ID: 10697892 [Abstract] [Full Text] [Related]
13. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity. Bongfen SE, Ntsama PM, Offner S, Smith T, Felger I, Tanner M, Alonso P, Nebie I, Romero JF, Silvie O, Torgler R, Corradin G. Vaccine; 2009 Jan 07; 27(2):328-35. PubMed ID: 18984024 [Abstract] [Full Text] [Related]
14. Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum. Etlinger HM, Felix AM, Gillessen D, Heimer EP, Just M, Pink JR, Sinigaglia F, Stürchler D, Takacs B, Trzeciak A. J Immunol; 1988 Jan 15; 140(2):626-33. PubMed ID: 3275719 [Abstract] [Full Text] [Related]
15. Genetic considerations in the design of a malaria vaccine. Rzepczyk CM. P N G Med J; 1989 Dec 15; 32(4):251-8. PubMed ID: 2483292 [Abstract] [Full Text] [Related]
16. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Heppner DG, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, Stewart VA, Dubois P, Lanar DE, Krzych U, Moris P, Angov E, Cummings JF, Leach A, Hall BT, Dutta S, Schwenk R, Hillier C, Barbosa A, Ware LA, Nair L, Darko CA, Withers MR, Ogutu B, Polhemus ME, Fukuda M, Pichyangkul S, Gettyacamin M, Diggs C, Soisson L, Milman J, Dubois MC, Garçon N, Tucker K, Wittes J, Plowe CV, Thera MA, Duombo OK, Pau MG, Goudsmit J, Ballou WR, Cohen J. Vaccine; 2005 Mar 18; 23(17-18):2243-50. PubMed ID: 15755604 [Abstract] [Full Text] [Related]
17. The development of malaria vaccines: SPf66--what next? Tanner M, Alonso PL. Schweiz Med Wochenschr; 1996 Jul 09; 126(27-28):1210-5. PubMed ID: 8766632 [Abstract] [Full Text] [Related]